Close Menu

If you're affiliated with a New York City-based university or research institute (or have a collaborator who is), heads up: Stephen Albainy-Jenei at Patent Baristas has a post about the opportunity to win $250,000 in funding through the BioAccelerate NYC Prize competition. Funded with up to $1.25 million, the program aims to boost commercialization of the biomedical research conducted in New York.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.